↓ Skip to main content

Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis

Overview of attention for article published in Clinical Gastroenterology and Hepatology, July 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
1 news outlet
twitter
37 X users
facebook
1 Facebook page

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
34 Mendeley
Title
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis
Published in
Clinical Gastroenterology and Hepatology, July 2021
DOI 10.1016/j.cgh.2021.07.038
Pubmed ID
Authors

Neeraj Narula, Emily C L Wong, John K Marshall, Jean-Frederic Colombel, Parambir S Dulai, Walter Reinisch

X Demographics

X Demographics

The data shown below were collected from the profiles of 37 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 21%
Student > Ph. D. Student 3 9%
Student > Doctoral Student 2 6%
Other 2 6%
Student > Postgraduate 2 6%
Other 3 9%
Unknown 15 44%
Readers by discipline Count As %
Medicine and Dentistry 12 35%
Computer Science 2 6%
Immunology and Microbiology 2 6%
Agricultural and Biological Sciences 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 1 3%
Unknown 15 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2022.
All research outputs
#1,321,279
of 26,192,167 outputs
Outputs from Clinical Gastroenterology and Hepatology
#504
of 4,791 outputs
Outputs of similar age
#31,371
of 445,224 outputs
Outputs of similar age from Clinical Gastroenterology and Hepatology
#23
of 108 outputs
Altmetric has tracked 26,192,167 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,791 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.3. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,224 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.